SOM Biotech announces the appointment of Marc Casellas as Chief Financial Officer. Mr Casellas has an extensive finance experience across the healthcare and venture capital sectors, especially in providing financing to life science companies at different stages of growth. Prior to joining SOM Biotech, Marc Casellas most recently served as Chief Financial Officer of Ysios Capital after holding finance positions at Danone Group and PwC Consulting.
Raúl Insa, CEO of SOM Biotech highlights: “Marc Casellas has a deep expertise in managing finance in biotech and in venture capital. He will provide all aspects of financial and administration leadership in support of driving value creation. It is a great time to incorporate Marc Casellas to our team, to further align financial strategy with our corporate goals. We look forward to strengthening our management team as we enter our next phase of growth.”